Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

ONDE Aktie

>ONDE Performance
1 Woche: -3,4%
1 Monat: -4,0%
3 Monate: +1,8%
6 Monate: -8,2%
1 Jahr: -29,8%
laufendes Jahr: +1,8%
>ONDE Aktie
Name:  ONDE S.A. ZY -,02
Land:  Polen
Sektor:  Versorger
ISIN/ Wkn:  PLONDE000018 / A3CVP8
Symbol/ Ticker:  0XF (Frankfurt)
Kürzel:  FRA:0XF, ETR:0XF, 0XF:GR
Index:  -
Webseite:  https://onde.pl/
Profil:  Onde S.A. is a leading renewable energy company specializing in the development, construction, and maintenance of photovoltaic solar power plants. The primary function of Onde S.A. is to provide sustainable energy solutions by harnessing solar power,..
>Volltext..
Marktkapitalisierung:  113.21 Mio. EUR
Unternehmenswert:  120.25 Mio. EUR
Umsatz:  205.35 Mio. EUR
EBITDA:  12.29 Mio. EUR
Nettogewinn:  6.45 Mio. EUR
Gewinn je Aktie:  0.12 EUR
Schulden:  32.9 Mio. EUR
Liquide Mittel:  25.75 Mio. EUR
Operativer Cashflow:  23.24 Mio. EUR
Bargeldquote:  0.36
Umsatzwachstum:  4.65%
Gewinnwachstum:  -13.41%
Dividende je Aktie:  0.07 EUR
Dividendenrendite:  3.51%
Dividendenschätzung:  3.8%
Div. Historie:  26.05.25 - 0.0730918€
17.05.24 - 0.073804796€
Insiderhandel:  -
Suchwörter:  ONDE
Letzte Datenerhebung:  05.04.26
>ONDE Kennzahlen
Aktien/ Unternehmen:
Aktien: 54.51 Mio. St.
Frei handelbar: 32%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 542
Umsatz/Mitarb.: 0.31 Mio. EUR
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: 21.23
KGV lG: -
KUV: 0.54
KBV: 1.6
PEG-Ratio: -
EV/EBITDA: 9.79
Rentabilität:
Bruttomarge: 12.61%
Gewinnmarge: 3.14%
Operative Marge: 4.38%
Managementeffizenz:
Gesamtkaprendite: 3.52%
Eigenkaprendite: 7.66%
>ONDE Peer Group
Versorger, Stromerzeugung aus erneuerbarer Energie
 
17.03.26 - 18:06
ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL (Business Wire)
 
WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1100972. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...
03.02.26 - 18:03
ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL (Business Wire)
 
WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the French Financial Markets Authority (AMF) via ONDE, the centralized information filing system, regarding the sale of a new block of ABL Diagnostics shares as part of an over-the-counter transaction with a private third party. The filing relating to this sale can be viewed in the AMF's database of decisions and financial information (BDIF) at the following address: https://bdif.amf-france.org/fr/details/2026DD1092130. With the support of its main shareholder, ABL, ABL Diagnostics is continuing its efforts to enhance its visibility among all stakeholders (investors, partners, customers, and employees). About ABL Diagnostics (ABLD) ABL Diagnostics (ABLD) is an international company that specializes in innovative molecular biology tests and global solutions for its customers: Molecular ...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!